Currently viewing the category:
"DanDrit"
Danish stocks
By Karl M. Bidstrup On 20. September 2013 · Leave a Comment · In BioPorto, Coloplast, DanDrit, Exiqon, Genmab, Topotarget, Veloxis, Zealand
XEO Dr. eric Leire har sendt en lille nytårshilsen ud
Fra: Eric Leire [mailto:EPL@dandrit.com]
Sendt: 20. januar 2013 12:07
Til: Eric Leire
Emne: FW: DanDrit Biotech enters 2013 with confidence.
Dear friends of DanDrit Biotech,
2012 has seen a record number of 39 FDA drug approvals (including 11 new cancer drugs). This […]
Yesterday DKTI made an announcement regarding the ongoing talks with Dandrit A/S. Apparantly the status of DKTI a7s as an investment company raises some tax-issues with regard to the proposed merger.
The solution has therefore been that Dandrit shareholders get new shares in DKTI A/S (a swap if you will). General Assembly to be held […]
Dandrit is given a chance to measure up the competition at the Cancer Vaccine Conference in Boston late june…
Speakers are amongst others: dendreon, Bristol-Myers Squibb, Immunovaccine, Novartis, AstraZeneca, all among the top tier cancer vaccine companies of the world
the whole program is available here:
http://medicoinvestor.com/wp-content/uploads/2012/06/agenda.pdf
DanDrit will be represented by Dr. Eric Leire, […]
Dandrit ‘s technique is based on Dendritic Cells, garland science made this easy-to-understand youtube video on the development of Dendritic Cells
http://www.youtube.com/watch?v=ZuccruG_79M
this stops at where the T-cells enters :)…
but don’t despair I’ve found another from KhanAcademy.org on the cytotoxic T-cells http://www.youtube.com/watch?v=xaz5ftvZCyI&feature=related (these are the cells that attack cancer-cells)
So far the only FDA approved […]
As some of you know, Dandrit is planning a merger with DKTI A/S a company listed on the danish stock exchange.
DKTI is cash rich but with no real purpose, quite the oppsite to Dandrit – who is a company with a message – but precious little cash. So it looks like a match made […]
Dandrit strengthens its European Patent base. This company has potential of surpassing rival Dendreon in the field of Cancer Vaccine Astonishing – but true….
Dandrit A/s is through merger of cash-rich DKTI A/S securing a financial platform for expansion and a platform on the Copenhagen Stock Exchange. Ongoing talks – that were first publicized late […]
Danske aktier
By Karl M. Bidstrup On 7. May 2011 · Leave a Comment · In BioPorto, Coloplast, DanDrit, Exiqon, Genmab, Topotarget, Veloxis, Zealand
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
